| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RENOVARO INC. | Director | Option to purchase shares of common stock | 42,857 | 25 Jun 2024 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 15,583 | 02 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO INC. | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 18:54 |
| RENB | RENOVARO INC. | 27 Dec 2023 | 1 | $0 | 4 | Director | 28 Feb 2024, 15:20 |
| RENB | Enochian Biosciences Inc | 27 Dec 2022 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:47 |
| MIRM | Mirum Pharmaceuticals, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 18:01 |
| RENB | Enochian Biosciences Inc | 27 Dec 2021 | 1 | $0 | 4 | Director | 03 Jan 2022, 05:01 |
| MIRM | Mirum Pharmaceuticals, Inc. | 04 Jun 2021 | 1 | $0 | 4 | Director | 08 Jun 2021, 16:57 |
| MIRM | Mirum Pharmaceuticals, Inc. | 04 Jun 2021 | 0 | $0 | 3 | Director | 08 Jun 2021, 16:53 |
| RENB | Enochian Biosciences Inc | 06 Apr 2020 | 2 | $0 | 4 | Director | 21 Dec 2021, 10:50 |